Could Epstein-Barr Virus or Canine Distemper Virus Cause Multiple Sclerosis?

Neurologic Clinics

Volumn 26, Issue 3, 2008, Pages 699-715

  Lincoln, John A ^a   Hankiewicz, Karolina ^b   Cook, Stuart D ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; PLACEBO; VALACICLOVIR;

AUTOIMMUNE DISEASE; CANINE DISTEMPER MORBILLIVIRUS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; HEREDITY; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEROLOGY;

ANIMALS; AXONS; BRAIN; CLIMATE; DEMYELINATING DISEASES; DISTEMPER VIRUS, CANINE; DOGS; ENVIRONMENT; HERPESVIRUS 4, HUMAN; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEURONS;

EID: 47649127789     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2008.03.004     Document Type: Review

References (94)

1. Orton S.M., Herrera B.M., Yee I.M., et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5 (2006) 932-936
2. Weinshenker B.G. The natural history of multiple sclerosis. Neurol Clin 13 (1995) 119-146
3. Marrie R.A., Wolfson C., Stukenboom M.C., et al. Multiple sclerosis and antecedent infections: a case-control study. Neurology 54 (2000) 2307-2310
4. Bielekova B., Richert N., Howard T., et al. Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc Natl Acad Sci U S A 101 (2004) 8705-8708
5. Lundmark F., Duvefelt K., Iacobaeus E., et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39 (2007) 1108-1113
6. Sadovnick A.D., Armstrong H., Rice G.P.A., et al. A population based study of multiple sclerosis in twins: update. Ann Neurol 33 (1993) 281-285
7. van der Mei I.A., Ponsonby A.L., Blizzard L., et al. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 20 (2001) 168-174
8. Goldberg P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part 1: sunlight, dietary factors and epidemiology. Int J Environ Stud 6 (1974) 19-27
9. Hernán M.A., Olek M.J., and Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 154 (2001) 69-74
10. Hernán M.A., Jick S.S., Logroscino G., et al. Cigarette smoking and the progression of multiple sclerosis. Brain 128 (2005) 1461-1465
11. Gale C.R., and Martyn C.N. Migrant studies in multiple sclerosis. Prog Neurobiol 47 (1995) 425-448
12. Elian M., Nightingale S., and Dean G. Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry 53 (1990) 906-911
13. Dean G., and Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 63 (1997) 565-568
14. Poskanzer D.C., Walker A.M., Yonkondy J., et al. Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology 26 (1976) 14-17
15. Kurtzke J.F. MS epidemiology worldwide: one view of current status. Acta Neurol Scand 161 (1995) 23-33
16. Leibowitz U., Antonovsky A., Medalie J.M., et al. Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 29 (1966) 60-68
17. Fingeroth J.D., Weis J.J., Tedder T.F., et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A 81 (1984) 4510-4514
18. Cohen J.I. Epstein-Barr virus infection. N Engl J Med 343 (2000) 481-492
19. Wolfson C. Multiple sclerosis and antecedent infections. Epidemiology 12 (2001) 298-299
20. Hernan M.A., Zhang S.M., Lipworth L., et al. Multiple sclerosis and age at infection with common viruses. Epidemiology 12 (2001) 301-306
21. Operskalski E.A., Visscher B.R., Malmgren R.M., et al. A case-control study of multiple sclerosis. Neurology 39 (1989) 825-829
22. Lindberg C., Andersen O., Vahlne A., et al. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 10 (1991) 62-65
23. Haahr S., Koch-Henriksen N., Moller-Larsen A., et al. Increased risk of multiple sclerosis after late Epstein Barr virus infection. Mult Scler 1 (1995) 73-77
24. Ascherio A., and Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61 (2007) 288-299
25. MacGregor H.S., and Latiwonk Q.I. Is multiple sclerosis and autoimmune disease or a chronic gammaherpes virus infection?. J Clin Lab Immunol 48 (1996) 45-74
26. Evans A.S. E.B. virus antibody in systemic lupus erythematosus. Lancet 1 (1971) 1023-1024
27. Barzilai O., Sherer Y., Ram M., et al. Epstein-Barr virus and cytomegalovirus in autoimmune diseases are they truly notorious? A preliminary report. Ann N Y Acad Sci 1108 (2007) 567-577
28. Bray P.F., Culp K.W., McFarlin D.E., et al. Demyelinating disease alter neurologically complicated primary Epstein-Barr virus infection. Neurology 42 (1992) 278-282
29. Fujimoto H., Asaoka K., Imaizumi T., et al. Epstein-Barr virus infections of the central nervous system. Intern Med 42 (2003) 33-40
30. Imai S., Usui N., Sugiura M., et al. Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infection. J Med Virol 40 (1993) 278-284
31. Takahashia K., Kunishigea M., Shinoharaa M., et al. Guillain-Barré syndrome and hemophagocytic lymphohistiocytosis in a patient with severe chronic active Epstein-Barr virus infection syndrome. Clin Neurol Neurosurg 108 (2005) 80-83
32. Pender M.P. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 24 (2003) 584-588
33. Cook S.D. Does Epstein-Barr virus cause multiple sclerosis?. Rev Neurol Dis 1 (2004) 115-123
34. Sumaya C.V., Myers L.W., Ellison G.W., et al. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 17 (1985) 371-377
35. Larsen P.D., Bloomer L.C., and Bray P.F. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 35 (1985) 435-438
36. Alotaibi S., Kennedy J., Tellier R., et al. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291 (2004) 1875-1879
37. Lünemann J.D., and Münz C. Epstein-Barr virus and multiple sclerosis. Curr Neurol Neurosci Rep 7 (2007) 253-258
38. Pohl D., Krone B., Rostasy K., et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67 (2006) 2063-2065
39. Banwell B., Krupp L., Kennedy J., et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6 (2007) 773-781
40. Levin L.I., Munger K.L., Rubertone M.V., et al. Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 239 (2005) 2496-2500
41. DeLorenze G.N., Munger K.L., Lennette E.T., et al. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63 (2006) 839-844
42. Sundström P., Juto P., Wadell G., et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 62 (2004) 2277-2282
43. Rand K.H., Houck H., Denslow N.D., et al. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis. J Neurol Sci 173 (2000) 32-39
44. Cepok S., Zhou D., Srivastava R., et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115 (2005) 1352-1360
45. Wandinger K.P., Jabs W., Siekhaus A., et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 55 (2000) 178-184
46. Buljevac D., van Doornum G.J.J., Flach H.Z., et al. Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 76 (2005) 1377-1381
47. Ascherio A., Munger K.L., Lennette E.T., et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286 (2001) 3083-3088
48. Serafi B., Rosicarelli B., Franciotta D., et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204 (2007) 2899-2912
49. Opsahl M.L., and Kennedy P.G. An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue. J Neurol 254 (2007) 425-430
50. Sanders V.J., Felisan S., Waddell A., et al. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 2 (1996) 249-258
51. Lünemann J.D., Edwards N., Muraro P.A., et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129 (2006) 1493-1506
52. Swanson-Mungerson M., and Longnecker R. Epstein-Barr virus latent membrane protein 2A and autoimmunity. Trends Immunol 28 (2007) 213-218
53. Lünemann J.D., Kamradt T., Martin R., et al. Epstein-Barr virus: environmental trigger of multiple sclerosis?. J Virol 81 (2007) 6777-6784
54. Lycke J., Svennerholm B., Hjelmquist E., et al. Acyclovir treatment of relapsing-remitting multiple sclerosis: a randomized, placebo-controlled, double-blind study. J Neurol 243 (1996) 214-224
55. Bech E., Lycke J., Gadeberg P., et al. A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology 58 (2002) 31-36
56. Friedman J.E., Zabriskie J.B., Plank C., et al. A randomized clinical trial of valacyclovir in multiple sclerosis. Mult Scler 11 (2005) 286-295
57. Harder T.C., and Osterhaus A.D. Canine distemper virus: a morbillivirus in search of new hosts?. Trends Microbiol 5 (1997) 120-124
58. Yoshikawa Y., Ochikubo F., Matsubara Y., et al. Natural infection with canine distemper virus in a Japanese monkey (Macaca fuscata). Vet Microbiol 20 (1989) 193-205
59. Appel M.J., Reggiardo C., Summers B.A., et al. Canine distemper virus infection and encephalitis in javelinas (collared peccaries). Arch Virol 119 (1991) 147-152
60. Appel M.J., Yates R.A., Foley G.L., et al. Canine distemper epizootic in lions, tigers, and leopards in North America. J Vet Diagn Invest 6 (1994) 277-288
61. Rudd P.A., Cattaneo R., and Von Messling V. Canine distemper virus: review of structural and functional modulations in lymphoid tissues. J Virol 80 (2006) 9361-9370
62. Vandevelde M., Higgins R.J., Kristensen B., et al. Demyelination in experimental canine distemper virus infection; immunological, pathologic and immunohistological studies. Acta Neuropathol 56 (1982) 285-293
63. Cook S.D., Rohowsky-Kochan C., Bansil S., et al. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand Suppl 161 (1995) 34-42
64. Cook S.D. Epidemiology of multiple sclerosis: clues to etiology of a mysterious disease. Neuroscientist 2 (1996) 172-180
65. Vandevelde M., and Zubriggen A. Demyelination in canine distemper virus infection: a review. Acta Neuropathol 109 (2005) 56-68
66. Blixenkrone-Møllera M., Svanssona V., Have P., et al. Studies on manifestations of canine distemper virus infection in an urban dog population. Vet Microbiol 37 (1993) 163-173
67. Lednicky J.A., Dubach J., Kinsel M.J., et al. Genetically distant American canine distemper virus lineages have recently caused epizootics with somewhat different characteristics in raccoons living around a large suburban zoo in the USA. Virol J 1 (2004) 1-14
68. Cook S.D., Natelson B.H., Levin B.E., et al. Further evidence of a possible association between house dogs and multiple sclerosis. Ann Neurol 3 (1978) 141-143
69. Norman J., Cook S.D., and Dowling P.C. Pilot survey of household pets among veterans with multiple sclerosis and age-matched controls. Arch Neurol 40 (1983) 213-214
70. Chan W.W. Multiple sclerosis and dogs. Lancet 1 (1977) 487-488
71. Bansil S., Singhal B.S., Ahuja G.K., et al. Multiple sclerosis in India: a case control study of environmental exposures. Acta Neurol Scand 95 (1997) 208-210
72. Murray K., Selleck P., Hooper P., et al. A morbillivirus that caused fatal disease in horses and humans. Science 268 (1995) 94-97
73. Warren S.A., Warren K.G., Greenhill S., et al. How multiple sclerosis is related to animal illness, stress and diabetes. Can Med Assoc J 55 (1982) 359-367
74. Hall A.J. Morbilliviruses in marine mammals. Trends Microbiol 31 (1995) 4-9
75. Kennedy S. Morbillivirus infections in aquatic mammals. J Comp Pathol 119 (1998) 201-225
76. Gordon M.T., Mee A.P., Anderson D.C., et al. Canine distemper virus transcripts sequenced from pagetic bone. Bone Miner 19 (1992) 159-174
77. von Messling V., Milosevic D., and Cattaneo R. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A 101 (2004) 14216-14221
78. Cook S.D., Dowling P.C., and Russell W.C. Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis. J Neurol Sci 41 (1979) 61-70
79. Appel M.J., Glickman L.I., Raine C.S., et al. Viruses and multiple sclerosis. Neurology 31 (1981) 944-949
80. Rohowsky-Kochan C., Dowling P.C., and Cook S.D. Canine distemper virus-specific antibodies in multiple sclerosis. Neurology 45 (1995) 1554-1560
81. Geeraedts F., Wilczak N., van Binnendijk R., et al. Search for morbillivirus proteins in multiple sclerosis brain tissue. Neuroreprot 15 (2004) 27-32
82. Higgins R.J., Krakowka S.G., Metzler A.E., et al. Primary demyelination in experimental canine distemper virus induced encephalomyelitis in gnotobiotic dogs: sequential immunologic and morphologic findings. Acta Neuropathol 58 (1982) 1-8
83. Vandevelde M., Zurbriggen A., Higgins R.J., et al. Spread and distribution of viral antigen in nervous canine distemper. Acta Neuropathol 67 (1985) 211-218
84. Zurbriggen A., Schmid I., Graber H., et al. Oligodendroglial pathology in canine distemper. Acta Neuropathol 95 (1998) 71-77
85. Vandevelde M., Zurbriggen A., Steck A., et al. Studies on the intrathecal humoral immune response in canine distemper encephalitis. J Neuroimmunol 11 (1986) 41-51
86. Glaus T.C., Griot C., Richard A., et al. Ultrastructural and biochemical findings in brain cell cultures infected with canine distemper virus. Acta Neuropathol 80 (1990) 59-67
87. Graber H., Muller C., Vandevelde A., et al. Restricted infection with canine distemper virus leads to down-regulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol 97 (1999) 179-187
88. Tipold A., Vandevelde M., Wittek R., et al. Partial protection and intrathecal invasion of CD8(+) T cells in acute canine distemper virus infection. Vet Microbiol 83 (2001) 189-203
89. Vandevelde M., Fankhauser R., Kristensen F., et al. Immunoglobulins in demyelinating lesions in canine distemper encephalitis: an immunohistological study. Acta Neuropathol 54 (1981) 31-41
90. Markus S., Failing K., and Baumgartner W. Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper lesions. J Neuroimmunol 125 (2002) 30-41
91. Wünschmann A., Kremmer E., and Baumgärtner W. Phenotypical characterization of T and B cell areas in lymphoid tissues of dogs with spontaneous distemper. Vet Immunol Immunopathol 73 (2000) 83-98
92. Griot C., Burge T., Vandevelde M., et al. Antibody-induced generation of reactive oxygen radicals by brain macrophages in canine distemper encephalitis: a mechanism for bystander demyelination. Acta Neuropathol 78 (1989) 396-403
93. De Keyser J., Wilczak N., Walter J.H., et al. Disappearance of beta2-adrenergic receptors on astrocytes in canine distemper encephalitis: possible implications for the pathogenesis of multiple sclerosis. Neuroreport 12 2 (2001) 191-194
94. De Keyser J., Zeinstra E., and Frohman E. Are astrocytes central players in the pathophysiology of multiple sclerosis?. Arch Neurol 60 (2003) 132-136